The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the college of American pathologists and the American society for colposcopy and cervical pathology

International Journal of Gynecological Pathology

Volumn 32, Issue 1, 2013, Pages 76-115

  Darragh, Teresa M ^a   Colgan, Terence J ^b   Thomas Cox, J ^c   Heller, Debra S ^d   Henry, Michael R ^e   Luff, Ronald D ^f,g   McCalmont, Timothy ^a   Nayar, Ritu ^h   Palefsky, Joel M ^a   Stoler, Mark H ⁱ   Wilkinson, Edward J ^j   Zaino, Richard J ^k   Wilbur, David C ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e MAYO CLINIC   (United States)

^f QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Human papillomavirus; Intraepithelial neoplasia; Microinvasive carcinoma; p16; Squamous intraepithelial lesion; Superficially invasive carcinoma; terminology

Indexed keywords

BIOLOGICAL MARKER;

ANUS INJURY; ARTICLE; BOWENOID PAPULOSIS; CONDYLOMA ACUMINATUM; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS ASSOCIATED SQUAMOUS LESION; INVASIVE CARCINOMA; KNOWLEDGE; MEDICAL SOCIETY; MEDICAL TERMINOLOGY; PAPILLOMAVIRUS INFECTION; PATIENT CARE; PRIORITY JOURNAL; SCROTUM DISORDER; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; UTERINE CERVIX CARCINOMA; VULVA DISEASE;

ANUS NEOPLASMS; CARCINOMA IN SITU; COLPOSCOPY; FEMALE; HUMANS; MALE; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, CLINICAL; PRECANCEROUS CONDITIONS; REFERENCE STANDARDS; TERMINOLOGY AS TOPIC; UROGENITAL NEOPLASMS;

EID: 84871664880     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31826916c7     Document Type: Article

References (180)

1. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007;23:297-313. (Pubitemid 47015790)
2. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32(Suppl 1): S7-15. (Pubitemid 40332584)
3. Stoler MH. The pathology of cervical neoplasia. In: Rohan TE, Shah KV, eds. Cervical Cancer: From Etiology to Prevention. New York: Springer; 2004:3-60.
4. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000;19:16-28. (Pubitemid 30010639)
5. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9. (Pubitemid 34437346)
6. Stoler MH, Vichnin MD, Ferenczy A, et al. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011;128:1354-62.
7. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72. (Pubitemid 44305665)
8. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430-4. (Pubitemid 39178694)
9. Pretorius RG, Belinson JL, Burchette RJ, et al. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis 2011;15:180-8.
10. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA 2001; 285:1500-5. (Pubitemid 32221899)
11. Mccredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
12. Mccredie MR, Paul C, Sharples KJ, et al. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust N Z J Obstet Gynaecol 2010;50:363-70.
13. Jones RW. Vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2001;46:408. (Pubitemid 32428793)
14. Jones RW. Vulval intraepithelial neoplasia: Current perspectives. Eur J Gynaecol Oncol 2001;22:393-402. (Pubitemid 34160722)
15. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and metaanalysis. Lancet Oncol 2012; Forthcoming.
16. Williams J, eds. On Cancer of the Uterus: Being the Harveian Lectures for 1886. London: Lewis. H. K; 1888.
17. Cullen TS, eds. Cancer of the Uterus: Its Pathology, Symptomatology, Diagnosis, and Treatment. New York: Appleton; 1900.
18. Rubin IC. The pathological diagnosis of incipient carcinoma of the cervix. Am J Obstet Gynecol 1910;62:668-76.
19. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932;99:1670-74.
20. Reagan JW, Hicks DJ. A study of in situ and squamous-cell cancer of the uterine cervix. Cancer 1953;6:1200-14.
21. Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer 1953;6:224-34.
22. Mckelvey JL. Carcinoma in situ of the cervix: a general consideration. Am J Obstet Gynecol 1952;64:816-32.
23. Hoffman J, Farell DM, Hahn GA. Review of 4,152 biopsies of the cervix with relation to carcinoma in situ. JAMA 1953;151:535-40.
24. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956;63: 1245-61.
25. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976;20:505-9. (Pubitemid 8012639)
26. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105:386-93.
27. Koss LG. Dysplasia. A real concept or a misnomer? Obstet Gynecol 1978;51:374-9. (Pubitemid 8283180)
28. Robertson AJ, Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8. (Pubitemid 19077263)
29. Ismail SM, Colclough AB, Dinnen JS, et al. Reporting cervical intra-epithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement. Histopathology 1990;16:371-6. (Pubitemid 20138557)
30. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990;75:131-3.
31. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4.
32. Wright TC, Jr. Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189: 295-304.
33. Wright TC, Jr Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-5. (Pubitemid 47464166)
34. Heatley MK. How should we grade CIN? Histopathology 2002;40:377-90. (Pubitemid 34595590)
35. Crum CP. Symposium part 1: Should the Bethesda System terminology be used in diagnostic surgical pathology?: Point. Int J Gynecol Pathol 2003;22:5-12. (Pubitemid 36014268)
36. Schneider V. Symposium part 2: Should the Bethesda System terminology be used in diagnostic surgical pathology?: Counterpoint. Int J Gynecol Pathol 2003;22:13-7. (Pubitemid 36014269)
37. Herbert A, Arbyn M, Bergeron C. Why CIN3 and CIN2 should be distinguished on histological reports. Cytopathology 2008;19:63-4.
38. Boonlikit S, Srisantiroj N. Is there any clinical advantage in separating CIN2 from CIN3 in the current two-tiered cytological classification? Asian Pac J Cancer Prev 2009; 10:115-8.
39. Bellino R, Wierdis T, Arisio R, et al. Microinvasive carcinoma of the uterine cervix. Diagnostic and therapeutic dilemma. Eur J Gynaecol Oncol 1994;15:380-5. (Pubitemid 24302431)
40. Woodruff JD. Carcinoma in situ of the vagina. Clin Obstet Gynecol 1981;24:485-501. (Pubitemid 12133128)
41. Mccartney AJ. Surgery of intraepithelial neoplasia, CIN, VaIN, and VIN. Baillieres Clin Obstet Gynaecol 1987;1:447-84.
42. Turell R. Epidermoid squamous cell cancer of the perianus and anal canal. Surg Clin North Am 1962;42:1235-41.
43. Oriel JD, Whimster IW. Carcinoma in situ associated with virus-containing anal warts. Br J Dermatol 1971;84:71-3.
44. Durst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-5. (Pubitemid 13063146)
45. lARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses. Lyon, France: lnternational Agency for Research on Cancer; 1995.
46. Fenger C, Bichel P. Flow cytometric DNA analysis of anal canal epithelium and ano-rectal tumours. Acta Pathol Microbiol Scand A 1981;89:351-5. (Pubitemid 11008510)
47. Fenger C, Nielsen VT. Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. Acta Pathol Microbiol Scand A 1986;94:343-9. (Pubitemid 16006507)
48. Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am 1996;10:1177-87. (Pubitemid 26314142)
49. Rickert RR, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: a basis for checklists. Cancer committee of the College of American Pathologists. Arch Pathol Lab Med 2000;124:21-5. (Pubitemid 30053768)
50. Wendell-Smith CP. Anorectal nomenclature: Fundamental terminology. Dis Colon Rectum 2000;43:1349-58.
51. Bilimoria KY, Bentrem DJ, Rock CE, et al. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: Analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009;52:624-31.
52. Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
53. Bowen JT. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis Syph 1912;30:241-55.
54. Woodruff JD, Hildebrandt EE. Carcinoma in situ of the vulva. Obstet Gynecol 1958;12:414-24.
55. Abell MR, Gosling Jr. Intraepithelial and infiltrative carcinoma of vulva: Bowen's type. Cancer 1961;14:318-29.
56. Friedrich EG, Jr. Reversible vulvar atypia. A case report. Obstet Gynecol 1972;39:173-81.
57. Wade TR, Ackerman AB. Bowenoid papulosis. JAMA. 1981;246:732-33. (Pubitemid 11044322)
58. Friedrich EG, Jr. New nomenclature for vulvar disease: report of the committee on terminology. Obstet Gynecol 1976;47: 122-24.
59. Crum CP, Fu YS, Levine RU, et al. Intraepithelial squamous lesions of the vulva: biologic and histologic criteria for the distinction of condylomas from vulvar intraepithelial neoplasia. Am J Obstet Gynecol 1982;144:77-83. (Pubitemid 12054360)
60. Wilkinson EJ, Kneale B, Lynch PJ. Report of the ISSVD terminology committee. J Reprod Med 1986;31:973-74. (Pubitemid 17170413)
61. Scully RE, Poulsen HE, eds. Histological Typing of Female Genital Tract Tumours. 2nd ed. Berlin; New York: Springer- Verlag; 1994.
62. Gross G, Ikenberg H, Gissmann L, et al. Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985;85:147-52. (Pubitemid 15007101)
63. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar oncology subcommittee. J Reprod Med 2005;50: 807-10. (Pubitemid 41720964)
64. Kurman RJ, Ronnett J, Sherman ME, et al, eds. Atlas of Tumor Pathology: Tumors of the Cervix, Vagina, and Vulva. Washington, D.C.: Armed Forces Institute of Pathology, American Registry of Pathology; 2010.
65. Barclay DL, Collins CG. Intraepithelial cancer of the vulva. Am J Obstet Gynecol 1963;86:95-106.
66. Kaufman RH. Intraepithelial carcinoma of the vulva. Obstet Gynecol Annu 1977;6:317-39. (Pubitemid 9003119)
67. Committee on Gynecologic Practice of American College Obstetricians and Gynecologists. ACOG committee opinion no. 509: Management of vulvar intraepithelial neoplasia. Obstet Gynecol 2011;118:1192-4.
68. Sulzberger MB, Satenstein DL. Erythroplasia of queyrat. AMA Arch Derm Syphilol 1933;28:798-806.
69. Della Torre G, Donghi R, Longoni A, et al. HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagn Mol Pathol 1992;1:25-30.
70. Cubilla AL, Reuter V, Velazquez E, et al. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 2001;9:111-20. (Pubitemid 32619729)
71. Epstein J, Cubilla AL, eds. Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum. Washington D.C.: Armed Forces Institute of Pathology, American Registry of Pathology; 2011.
72. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 99: Management of abnormal cervical cytology and histology. Obstet Gynecol 2008;112:1419-44.
73. Heller DS. Report of a new ISSVD classification of VIN. J Low Genit Tract Dis 2007;11:46-7. (Pubitemid 46052194)
74. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 2006;10:161-9. (Pubitemid 44618506)
75. Castle PE, Stoler MH, Solomon D, et al. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 2007;127:805-15.
76. Witkiewicz AK, Wright TC, Ferenczy A, et al. Carcinoma and other tumors of the cervix. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's Pathology of the Female Genital Tract.; 6th ed. New York: Springer; 2011.
77. Crum CP, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia: Saunders; 2005.
78. Tabbara S, Saleh AD, Andersen WA, et al. The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic, and viral correlates. Obstet Gynecol 1992;79: 338-46.
79. Genest DR, Stein L, Cibas E, et al. A binary (Bethesda) system for classifying cervical cancer precursors: Criteria, reproducibility, and viral correlates. Hum Pathol 1993;24: 730-6. (Pubitemid 23204650)
80. Mccluggage WG, Walsh MY, Thornton CM, et al. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol 1998;105: 206-10. (Pubitemid 28096302)
81. Mccluggage WG, Bharucha H, Caughley LM, et al. Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J Clin Pathol 1996;49:833-5. (Pubitemid 26338564)
82. Creagh T, Bridger JE, Kupek E, et al. Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia. J Clin Pathol 1995;48: 59-60.
83. Lie AK, Skjeldestad FE, Hagen B, et al. Occurrence of human papillomavirus infection in cervical intraepithelial neoplasia. A retrospective histopathological study of 317 cases treated by laser conization. APMIS 1995;103:693-8.
84. De Vet HC, Knipschild PG, Schouten HJ, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 1990;43:1395-8.
85. Kato I, Santamaria M, De Ruiz PA, et al. Inter-observer variation in cytological and histological diagnoses of cervical neoplasia and its epidemiologic implication. J Clin Epidemiol 1995;48:1167-74.
86. Preti M, Mezzetti M, Robertson C, et al. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an european collaborative study. Br J Obstet Gynaecol 2000;107:594-9. (Pubitemid 30242850)
87. Lytwyn A, Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447-56. (Pubitemid 40410742)
88. Dijkstra MG, Heideman DA, De Roy SC, et al. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 2010;63:972-7.
89. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99. (Pubitemid 35239415)
90. Bergeron C, Ordi J, Schmidt D, et al. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing highgrade cervical intraepithelial neoplasia. Am J Clin Pathol 2010;133:395-406.
91. Horn LC, Reichert A, Oster A, et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008;32: 502-12. (Pubitemid 351458292)
92. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop. J Reprod Med. 1992;37:383-6.
93. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24(Supplement 3): S11-S25. (Pubitemid 44404053)
94. Roche WD, Norris HJ. Microinvasive carcinoma of the cervix. The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer 1975;36:180-6.
95. Chitale AR, Bhuvaneshwari AP, Khilnani P, et al. Pathology of microinvasive (stage 1 A) carcinoma of uterine cervix. Indian J Cancer 1977;14:189-94.
96. Gurgel MS, Bedone AJ, Andrade LA, et al. Microinvasive carcinoma of the uterine cervix: Histological findings on cone specimens related to residual neoplasia on hysterectomy. Gynecol Oncol 1997;65:437-40. (Pubitemid 27255985)
97. Creasman WT, Fetter BF, Clarke-Pearson DL, et al. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-72. (Pubitemid 15232357)
98. Greer BE, Figge DC, Tamimi HK, et al. Stage IA2 squamous carcinoma of the cervix: Difficult diagnosis and therapeutic dilemma. Am J Obstet Gynecol 1990;162:1406-9; discussion 09-11.
99. Zheng W, Robboy SJ. Cervical squamous cell carcinoma. In: Robboy SJ, Mutter GL, Prat J, eds. Robboy's Pathology of the Female Reproductive Tract.; 2nd ed. Philadelphia: Churchill Livingstone/Elsevier; 2008:227-48.
100. Andersen ES, Husth M, Joergensen A, et al. Laser conization for microinvasive carcinoma of the cervix. Short-term results. Int J Gynecol Cancer 1993;3:183-85. (Pubitemid 23207606)
101. Simon NL, Gore H, Shingleton HM, et al. Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986;68:19-24. (Pubitemid 16090832)
102. Hopkins MP, Morley GW. Microinvasive squamous cell carcinoma of the cervix. J Reprod Med 1994;39:671-3. (Pubitemid 24294959)
103. Raspagliesi F, Ditto A, Solima E, et al. Microinvasive squamous cell cervical carcinoma. Crit Rev Oncol Hematol 2003;48:251-61. (Pubitemid 38018967)
104. Seski JC, Abell MR, Morley GW. Microinvasive squamous carcinoma of the cervix: definition, histologic analysis, late results of treatment. Obstet Gynecol 1977;50:410-4. (Pubitemid 8199582)
105. Ostor AG, Rome RM. Micro-invasive squamous cell carcinoma of the cervix: a clinico-pathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994;4:257-64.
106. Sevin BU. Management of microinvasive cervical cancers. Semin Surg Oncol 1999;16:228-31.
107. Ayhan A, Tuncer ZS, Koseoglu F, et al. Microinvasive carcinoma of the cervix: an analysis of 31 patients. Eur J Gynaecol Oncol 1997;18:127-29. (Pubitemid 27135852)
108. Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer 1980;45:928-31. (Pubitemid 10129842)
109. Trelford JD, Tesluk H, Franti CE, et al. 20 year follow-up on microinvasive squamous carcinoma of the cervix. Eur J Gynaecol Oncol 1992;13:155-59.
110. Copeland LJ, Silva EG, Gershenson DM, et al. Superficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:307-12.
111. Benedet JL, Anderson GH, Stage IA. carcinoma of the cervix revisited. Obstet Gynecol 1996;87:1052-9.
112. Sedlis A, Sall S, Tsukada Y, et al. Microinvasive carcinoma of the uterine cervix: a clinical-pathologic study. Am J Obstet Gynecol 1979;133:64-74. (Pubitemid 9098768)
113. Averette HE, Nelson JH, Ng AB, et al. Diagnosis and management of microinvasive (stage IA) carcinoma of the uterine cervix. Cancer 1976;38:414-25.
114. Burghardt E. Microinvasive carcinoma in gynaecological pathology. Clin Obstet Gynaecol 1984;11:239-57. (Pubitemid 14142095)
115. Burghardt E, Girardi F, Lahousen M, et al. Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics stage IA). Cancer 1991;67:1037-45.
116. Witkiewicz A, Lee KR, Brodsky G, et al. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS. Am J Surg Pathol 2005; 29:1609-14.
117. Kalof KN, Dadmanesh F, Longacre TA, et al. Protocol for the examination of specimens from patients with carcinoma of the uterine cervix Available from: http://www.cap.org/apps/docs/committees/cancer/cancer-protocols/2011/ Cervix-11protocol.pdf. Date Accessed: 04/10/2012.
118. Ostor AG, Mulvany N. The pathology of cervical neoplasia. Curr Opin Obstet Gynecol 1996;8:69-73. (Pubitemid 26112548)
119. Benedet JL. Cervical cancer staging systems: the endless debate. Gynecol Oncol 1997;65:6-7. (Pubitemid 27171544)
120. Ostor AG. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993;12:193-207. (Pubitemid 23182233)
121. Lee SW, Kim Y-M, Son W-S, et al. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand 2009;88:209-15.
122. Leman MH, Benson WL, Kurman RJ, et al. Microinvasive carcinoma of the cervix. Obstet Gynecol 1976;48:571-78.
123. Robert ME, Fu YS. Squamous cell carcinoma of the uterine cervix-a review with emphasis on prognostic factors and unusual variants. Semin Diagn Pathol 1990;7:173-89. (Pubitemid 20232100)
124. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Cancer 2009;105:103-4.
125. Pecorelli S, Odicino F. Cervical cancer staging. Cancer J 2003;9:390-4. (Pubitemid 44403493)
126. Yamaguchi H, Ueda M, Kanemura M, et al. Clinical efficacy of conservative laser therapy for early-stage cervical cancer. Int J Gynecol Cancer 2007;17:455-59. (Pubitemid 46426782)
127. Andersen ES, Nielsen K, Pedersen B. Combination laser conization as treatment of microinvasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 1998;19:352-5. (Pubitemid 28379203)
128. Elliott P, CopplesonM, Russell P, et al. Early invasive (FIGO stage IA) carcinoma of the cervix: A clinico-pathologic study of 476 cases. Int J Gynecol Cancer 2000;10:42-52. (Pubitemid 30219477)
129. Kolstad P. Follow-up study of 232 patients with stage IA1 and 411 patients with stage IA2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989;33:265-72. (Pubitemid 19148722)
130. Creasman WT, Weed JC. Microinvasive cancer vs occult cancer. Int J Radiat Oncol Biol Phys 1979;5:1871-72. (Pubitemid 10183173)
131. Schink JC, Lurain Jr. Microinvasive cervix cancer. Int J Gynaecol Obstet 1991;36:5-11.
132. Duncan ID, Walker J. Microinvasive squamous carcinoma of cervix in the Tayside region of Scotland. Br J Obstet Gynaecol 1977;84:67-70. (Pubitemid 8114977)
133. Orlandi C, Costa S, Terzano P, et al. Presurgical assessment and therapy of microinvasive carcinoma of the cervix. Gynecol Oncol 1995;59:255-60.
134. Mota F. Microinvasive squamous carcinoma of the cervix: Treatment modalities. Acta Obstet Gynecol Scand 2003;82: 505-09. (Pubitemid 36750701)
135. Buckley SL, Tritz DM, Van Le L, et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996;63:4-9. (Pubitemid 26337957)
136. Van Nagell JR, Greenwell N, Powell DF, et al. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983;145:981-91.
137. Costa S, Marra E, Martinelli GN, et al. Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer 2009;19:33-8.
138. Kodama J, Mizutani Y, Hongo A, et al. Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 2002;101: 192-95. (Pubitemid 34163268)
139. Kim WY, Chang S-J, Chang K-H, et al. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization. Int J Gynaecol Obstet 2010;109:110-12.
140. Marana HR, De Andrade JM, Matthes AC, et al. Carrara HH, Bighetti S. Microinvasive carcinoma of the cervix. Analysis of prognostic factors. Eur J Gynaecol Oncol 2001;22:64-66. (Pubitemid 32242448)
141. Lin H, Chang HY, Huang CC, et al. Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Int J Gynecol Cancer 2004;14:311-16. (Pubitemid 38533903)
142. Phongnarisorn C, Srisomboon J, Khunamornpong S, et al. The risk of residual neoplasia in women with microinvasive squamous cervical carcinoma and positive cone margins. Int J Gynecol Cancer 2006;16:655-59.
143. Jones WB, Mercer GO, Lewis JL, et al. Early invasive carcinoma of the cervix. Gynecol Oncol 1993;51:26-32. (Pubitemid 23339259)
144. Peters WA, Kumar NB, Morley GW. Microinvasive carcinoma of the vagina: a distinct clinical entity? Am J Obstet Gynecol 1985;153:505-07. (Pubitemid 16218445)
145. Dini MM, Park JM. Microinvasive squamous cell carcinoma of the vagina. J Natl Med Assoc 1984;76:709-11. (Pubitemid 14050767)
146. Wilkinson EJ. Pathology of the vagina. Curr Opin Obstet Gynecol 1991;3:553-60.
147. Shia J. An update on tumors of the anal canal. Arch Pathol Lab Med 2010;134:1601-11.
148. Salmo E, Haboubi N. Anal cancer: pathology, staging and evidence-based minimum data set. Colorectal Dis 2011; 13(Suppl 1): 11-20.
149. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763-6. (Pubitemid 15180494)
150. Martin FT, Kavanagh D, Waldron R. Squamous cell carcinoma of the anal canal. Surgeon 2009;7:232-7.
151. Klas JV, Rothenberger DA, Wong WD, et al. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686-93. (Pubitemid 29169668)
152. Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol 2008;15:263-78.
153. Roohipour R, Patil S, Goodman KA, et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008;51:147-53.
154. Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol 2009;113:895-901.
155. Faught W, Jeffrey J, Bryson P, et al. Management of squamous cell cancer of the vulva. J Obstet Gynaecol Can 2006;28:640-51.
156. Preti M, Rouzier R, Mariani L, et al. Superficially invasive carcinoma of the vulva: diagnosis and treatment. Clin Obstet Gynecol 2005;48:862-8. (Pubitemid 43019257)
157. Maiche AG, Pyrhonen S. Clinical staging of cancer of the penis: by size? By localization? Or by depth of infiltration? Eur Urol 1990;18:16-22. (Pubitemid 20226682)
158. Pizzocaro G, Algaba F, Horenblas S, et al. EAU Penile Cancer Guidelines 2009. Eur Urol 2010;57:1002-12.
159. Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am 1992;19:397-405.
160. Frisch M, Fenger C, Van Den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59:753-7. (Pubitemid 29076078)
161. Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004;13:263-75. (Pubitemid 38609353)
162. Stoler MH. Toward objective cervical cancer screening: Maybe the eyes do have it. Am J Clin Pathol 2010;134:5-6.
163. Galgano MT, Castle PE, Atkins KA, et al. Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 2010;34: 1077-87.
164. Santos M, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006;30:1347-56. (Pubitemid 44655467)
165. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92:276-84. (Pubitemid 32225381)
166. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-96. (Pubitemid 38881079)
167. Branca M, Giorgi C, Santini D, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005;124: 113-21. (Pubitemid 40944383)
168. Bernard JE, Butler MO, Sandweiss L, et al. Anal intraepithelial neoplasia: Correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization. Appl Immunohistochem Mol Morphol 2008;16:215-20. (Pubitemid 351589552)
169. Riethdorf S, Neffen EF, Cviko A, et al. p16INK4a expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004;35:1477-83. (Pubitemid 40017987)
170. Benevolo M, Terrenato I, Mottolese M, et al. Comparative evaluation of nm23 and p16 expression as biomarkers of highrisk human papillomavirus infection and cervical intraepithelial neoplasia 2(+) lesions of the uterine cervix. Histopathology 2010;57:580-6.
171. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical expression of p16(INK4a) is predictive of HRHPV infection in cervical low-grade lesions. Mod Pathol 2006;19:384-91. (Pubitemid 43276992)
172. Negri G, Vittadello F, Romano F, et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445: 616-20. (Pubitemid 40104537)
173. Ozaki S, Zen Y, Inoue M. Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions. Hum Pathol 2011;42: 1007-12.
174. Del Pino M, Garcia S, Fuste V, et al. Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol 2009;201:e1-7.
175. Ordi J, Garcia S, Del Pino M, et al. p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol 2009;28:90-7.
176. Katki HA, Wacholder S, Solomon D, et al. Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol 2009;10:1022-3.
177. Katki HA, KinneyWK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 2011;12:663-72.
178. Stoler MH, Wright TC, Jr. Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the Athena HPV study. Am J Clin Pathol 2011;135:468-75.
179. Wright TC, Jr. Stoler MH, Behrens CM, et al. The Athena human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206:e1-11.
180. College of American Pathologists. CAP laboratory accreditation checklists. Available from: http://www.cap.org/apps/cap.portal. Date Accessed: 04/11/2012.